| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7862384 | Journal of Controlled Release | 2016 | 26 Pages |
Abstract
Innovative polymeric system (IPS) facilitates the phase transition of the micron sized crystal lipophilic drug into a transdermally diffusible nano-sized amorphous form and fabrication of the backbone of DMNs for transdermal delivery. Due to the biodegradable properties of both IPS components, namely Hyaluronic Acid (HA) and Polyvinyl Pyrrolidone (PVP), the colloids can easily diffuse across the dermal layers allowing for efficacious powder based transdermal lipophilic drug delivery.89
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Manita Dangol, Huisuk Yang, Cheng Guo Li, Shayan Fakhraei Lahiji, Suyong Kim, Yonghao Ma, Hyungil Jung,